Literature DB >> 35475123

Computational maturation of a single-domain antibody against Aβ42 aggregation.

Jiacheng Lin1, Chiara Figazzolo1, Michael A Metrick1, Pietro Sormanni1, Michele Vendruscolo1.   

Abstract

The expansion of structural databases and the increase in computing power are enabling approaches for antibody discovery based on computational design. It has already been shown that it is possible to use this approach to generate antibodies for specific epitopes on challenging targets. Here we describe an application of this procedure for antibody maturation through the computational design of mutational variants of increased potency. We illustrate this procedure in the case of a single-domain antibody targeting an epitope in the N-terminal region of Aβ42, a peptide whose aggregation is closely associated with Alzheimer's disease. We show that this approach enables the generation of an antibody variant with over 200-fold increased potency against the primary nucleation process in Aβ42 aggregation. Our results thus demonstrate that potentiated antibody variants can be obtained by computational maturation. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2021        PMID: 35475123      PMCID: PMC8901120          DOI: 10.1039/d1sc03898b

Source DB:  PubMed          Journal:  Chem Sci        ISSN: 2041-6520            Impact factor:   9.825


  34 in total

1.  Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process.

Authors:  Erik Hellstrand; Barry Boland; Dominic M Walsh; Sara Linse
Journal:  ACS Chem Neurosci       Date:  2009-10-09       Impact factor: 4.418

2.  Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins.

Authors:  Pietro Sormanni; Francesco A Aprile; Michele Vendruscolo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

3.  Reproducibility: Standardize antibodies used in research.

Authors:  Andrew Bradbury; Andreas Plückthun
Journal:  Nature       Date:  2015-02-05       Impact factor: 49.962

Review 4.  The Increasingly Human and Profitable Monoclonal Antibody Market.

Authors:  António L Grilo; A Mantalaris
Journal:  Trends Biotechnol       Date:  2018-06-23       Impact factor: 19.536

Review 5.  Next generation antibody drugs: pursuit of the 'high-hanging fruit'.

Authors:  Paul J Carter; Greg A Lazar
Journal:  Nat Rev Drug Discov       Date:  2017-12-01       Impact factor: 84.694

6.  Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons.

Authors:  Michael A Metrick; Natalia do Carmo Ferreira; Eri Saijo; Andrew G Hughson; Allison Kraus; Christina Orrú; Michael W Miller; Gianluigi Zanusso; Bernardino Ghetti; Michele Vendruscolo; Byron Caughey
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-22       Impact factor: 11.205

Review 7.  On exploring structure-activity relationships.

Authors:  Rajarshi Guha
Journal:  Methods Mol Biol       Date:  2013

Review 8.  Chemical kinetics for drug discovery to combat protein aggregation diseases.

Authors:  Paolo Arosio; Michele Vendruscolo; Christopher M Dobson; Tuomas P J Knowles
Journal:  Trends Pharmacol Sci       Date:  2014-02-20       Impact factor: 14.819

9.  Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β.

Authors:  Joseph W Arndt; Fang Qian; Benjamin A Smith; Chao Quan; Krishna Praneeth Kilambi; Martin W Bush; Thomas Walz; R Blake Pepinsky; Thierry Bussière; Stefan Hamann; Thomas O Cameron; Paul H Weinreb
Journal:  Sci Rep       Date:  2018-04-23       Impact factor: 4.379

10.  Rational design of a conformation-specific antibody for the quantification of Aβ oligomers.

Authors:  Francesco A Aprile; Pietro Sormanni; Marina Podpolny; Shianne Chhangur; Lisa-Maria Needham; Francesco S Ruggeri; Michele Perni; Ryan Limbocker; Gabriella T Heller; Tomas Sneideris; Tom Scheidt; Benedetta Mannini; Johnny Habchi; Steven F Lee; Patricia C Salinas; Tuomas P J Knowles; Christopher M Dobson; Michele Vendruscolo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.